AnalystsGavin Clark-GartnerGavin Clark-Gartner's Stock Forecasts
AnalystsGavin Clark-Gartner
Analyst Ranking
Top 29%
#1584 out of 5491 analysts
Average Return
+3.38%
Win Rate
55%30 out of 55
Risk vs Reward
Poor
Good
Gavin Clark-Gartner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Forte Biosciences IncFBRX | +284.54% | $19.99 | $76.87 | 2025-11-25 - 2026-08-11 | Buy |
Definium Therapeutics IncDFTX | +135.26% | $7.43 | $17.48 | 2025-01-28 - 2026-01-27 | Buy |
Argenx SeARGX | +76.16% | $354.13 | $623.82 | 2023-12-21 - 2024-12-20 | Buy |
Mirum Pharmaceuticals IncMIRM | +67.83% | $59.97 | $100.65 | 2025-08-08 - 2026-08-07 | Buy |
Dyne Therapeutics IncDYN | +54.48% | $17.29 | $26.71 | 2026-05-15 - 2026-08-11 | Buy |
Gavin Clark-Gartner Analyst Color
Get additional color on Gavin Clark-Gartner's coverage of popular stocks
Gavin Clark-Gartner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tenax Therapeutics IncTENX | 2 | Hold | $5.00 | +208.64% | Downgrades | a day ago |
Abbvie IncABBV | 9 | Buy | $260.00 | +3.96% | Maintains | 2 days ago |
Dianthus Therapeutics IncDNTH | 1 | Buy | $134.00 | +23.51% | Maintains | 9 days ago |
Compass Pathways PLCCMPS | 1 | Buy | $21.00 | +56.95% | Upgrades | a month ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Hold | $85.00 | +0.76% | Downgrades | a month ago |
Proqr Therapeutics NvPRQR | 2 | Buy | $6.00 | +212.50% | Maintains | a month ago |
C4 Therapeutics IncCCCC | 2 | Buy | $12.00 | +210.08% | Maintains | 2 months ago |
Avalyn Pharma IncAVLN | 1 | Buy | $51.00 | +43.82% | Initiates Coverage On | 3 months ago |
Vera Therapeutics IncVERA | 2 | Buy | $91.00 | +200.43% | Maintains | 3 months ago |
Dyne Therapeutics IncDYN | 2 | Buy | $33.00 | +23.55% | Maintains | 3 months ago |
Argenx SeARGX | 6 | Buy | $1,059.00 | +22.46% | Maintains | 3 months ago |
Mirum Pharmaceuticals IncMIRM | 6 | Buy | $138.00 | +40.49% | Maintains | 3 months ago |
Krystal Biotech IncKRYS | 2 | Buy | $300.00 | -8.27% | Maintains | 3 months ago |
Meiragtx Holdings PLCMGTX | 1 | Buy | $18.00 | +37.93% | Maintains | 4 months ago |
Jasper Therapeutics IncJSPR | 5 | Buy | $7.00 | +683.87% | Maintains | 4 months ago |
Damora Therapeutics IncDMRA | 1 | Buy | $46.00 | +51.52% | Initiates Coverage On | 5 months ago |
Evommune IncEVMN | 1 | Buy | $40.00 | +181.49% | Initiates Coverage On | 8 months ago |
Forte Biosciences IncFBRX | 1 | Buy | $65.00 | -15.44% | Initiates Coverage On | 9 months ago |
Definium Therapeutics IncDFTX | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
Cabaletta Bio IncCABA | 2 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $170.00 | N/A | Maintains | 2 years ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Inhibrx IncINBX1 | 1 | Buy | $60.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.